Thus, ST8SIA6 co-expressed genes and ST8SIA6 may drive multiple oncogenic pathways with abnormal glycosylation in cancer cells and serve as a potential tumor biomarker for colon cancer. This evidence concerns the gene ST8SIA6 and malignant colon neoplasm.